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Recent studies have suggested that oligodendrocyte development is likely to be under the control of a hierarchy of lineage-specific
transcription factors. In the developing mouse spinal cord, expression of Olig2, Sox10 and Nkx2.2 is sequentially up-regulated in cells of
oligodendrocyte lineage. These transcription factors play essential roles in oligodendrocyte specification and differentiation. However, the
regulatory relationship and functional interactions among these transcription factors have not been determined. In this study, we systematically
investigated the function and hierarchical relationship of Olig2, Sox10 and Nkx2.2 transcription factors in the control of oligodendrocyte
differentiation. It was found that over-expression of Olig2 is sufficient to induce Sox10, Nkx2.2 and precocious oligodendrocyte differentiation in
embryonic chicken spinal cord. Sox10 expression alone is also sufficient to stimulate ectopic oligodendrocyte differentiation and weakly induce
Nkx2.2 expression. Although genetic evidence indicated that Sox10 functions downstream of Olig2, Sox10 activity can modulate Olig2
expression. In addition, we presented evidence that the control of oligodendrocyte differentiation by Olig2, Sox10 and Nkx2.2 is a dosage-
dependent developmental process and can be affected by both haploinsufficiency and over-dosage.
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Recent studies have identified a large number of transcription
factors that are selectively expressed in cells of oligodendrocyte
(OL) lineage at specific stages of cellular development (Rowitch,
2004). Mounting evidence suggests that oligodendrocyte devel-
opment is tightly regulated by coordinated expression and
biochemical interactions of these lineage-specific transcription
factors. In the developing spinal cord, early oligodendrocyte
precursor cells (OPCs or OLPs) are induced from the Olig1/2+
pMN domain of the ventral neuroepithelium by Sonic hedgehog
(Shh) (Trousse et al., 1995; Pringle et al., 1996;Orentas et al., 1999;
Lu et al., 2000), from which motor neurons and OPCs are⁎ Corresponding author. Fax: +502 852 6228.
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doi:10.1016/j.ydbio.2006.10.007sequentially generated (Richardson et al., 2000; Spassky et al.,
2000; Miller, 2002). At slightly later stages, a small number of
OPCs are also generated from the dorsal spinal cord independent of
Shh signaling (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al.,
2005). It is estimated that approximately 10–15%ofmatureOLs in
the spinal cord have a dorsal origin (Richardson et al., 2006).
During gliogenesis stages, early OPCs delaminate from the
ventricular zone and subsequently undergo extensive migration to
populate all regions of the spinal cord. Regardless of their origins,
OPC cells initially express the Olig2 basic helix–loop–helix
(bHLH) transcription factor and retain its expression even after they
differentiate into mature oligodendrocytes (Lu et al., 2000;
Takebayashi et al., 2000; Zhou et al., 2000). Soon after their
birth,OPCcells progressively gain expression of other transcription
factors, notably the Sox10 HMG transcriptional regulator and the
Nkx2.2 homeodomain transcription factor. In embryonic spinal
cord, expression of Sox10 is selectively up-regulated in OPC cells
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mature OLs (Stolt et al., 2002). Nkx2.2 is initially expressed in the
p3 domain and its derived V3 interneurons (Briscoe et al.,
1999; Liu et al., 2003). However, at later stages, Nkx2.2
expression is specifically up-regulated in Olig2+ OPC cells
either immediately before they migrate out of the ventral
ventricular zone in chicken (Xu et al., 2000; Soula et al., 2001;
Zhou et al., 2001; Fu et al., 2002) or after they disperse into the
white matter region in rodents (Fu et al., 2002). Following OL
differentiation in the white matter, Nkx2.2 expression is
gradually down-regulated in differentiated oligodendrocytes
(Xu et al., 2000).
Recent molecular and genetic studies demonstrated thatOlig2,
Sox10 andNkx2.2 play distinct roles in OL lineage progression. It
has been shown that the Olig2 transcription factor is a primary
determinant of oligodendrocyte fate specification. In Olig2 null
mutants, OPC generation was completely abolished in the spinal
cord (Lu et al., 2002; Takebayashi et al., 2002; Zhou and
Anderson, 2002). However, expression of Olig2 alone in
embryonic chicken spinal cord did not promote OPC generation,
and co-expression of Nkx2.2 was required to promote ectopic
formation of OPC cells and precocious oligodendrocyte differ-
entiation (Sun et al., 2001; Zhou et al., 2001). The Nkx2.2
homeodomain transcription factor plays a crucial role in the
terminal differentiation of oligodendrocytes. Null mutation of
Nkx2.2 resulted in a dramatic delay and reduction of oligoden-
drocyte differentiation although the initial generation of Olig2+
OPCs in the mutants was not compromised (Qi et al., 2001).
It has been recently shown that Sox10 also possesses important
functions in promoting terminal differentiation of oligodendro-
cytes. In the absence of Sox10 activity, oligodendrocyte
differentiation in the spinal cord was dramatically inhibited or
delayed (Stolt et al., 2002; Lu et al., 2002). Conversely, over-
expression of Sox10 protein in heterologous cells lines can induce
gene expression from the myelin basic protein (MBP) promoter
(Stolt et al., 2002). However, it is not known whether the in vivo
expression of Sox10 has similar effects in the developing CNS.
Although the roles of Olig2, Sox10 and Nkx2.2 in
oligodendrocyte development have been extensively investi-
gated, the epistatic relationship and functional interactions of
these three transcription factors remain to be determined. In the
present study, we investigated their functional relationship and
presented the first in vivo evidence for the reciprocal regulation
of Olig2 and Sox10 expression in their induction of OL fate and
differentiation. Sox10 and Nkx2.2 function in parallel and
downstream of Olig2 to regulate OL maturation. The control of
OL differentiation by Olig2, Sox10 and Nkx2.2 is a dosage-
dependent developmental process, as suggested by the sig-
nificant delay of OL maturation in all three heterozygous mice.
Results
Expression of Olig2 is sufficient for inducing Sox10 and Nkx2.2
expression and precocious oligodendrocyte differentiation
Previous studies showed that Olig2 is primarily involved in
the early fate specification of OLs (Lu et al., 2002;Takebayashi et al., 2002; Zhou and Anderson, 2002).
However, Olig2 is continuously expressed in differentiating
and mature OPCs, raising the possibility that Olig2 may also
be involved in OL differentiation and maturation. To
investigate this possibility, we ectopically expressed Olig2 in
embryonic chicken spinal cords by in ovo electroporation and
then examined its effects on myelin gene expression and OL
differentiation after various time periods.
In contrast to the previous reports that Olig2 expression
alone was not sufficient to induce ectopic oligodendrocyte
development (Sun et al., 2001; Zhou et al., 2001), we found
that Olig2 expression was able to induce expression of the
early OPC marker Sox10 4 days after electroporation (at
cE6) (Figs. 1A–B). However, ectopic expression of Nkx2.2,
myelin basic protein (MBP) and myelin-associated glyco-
protein (MAG) was not observed at this stage (Figs. 1C–D;
data not shown). Intriguingly, following 1 more day of
Olig2 expression (at cE7), ectopic expression of Nkx2.2 and
myelin genes MBP, and MAG was then detected in the
electroporated side of the cord (Figs. 1E–J). Moreover,
nearly all the induced MAG+ oligodendrocytes co-expressed
Olig2 (Figs. 1I, J), suggesting a cell autonomous mechanism
for Olig2 induction of oligodendrocyte differentiation.
Therefore, Olig2 expression alone in the developing spinal
cord is capable of inducing both the early specification and
the maturation of OLs.
Expression of Sox10 is sufficient for inducing precocious
oligodendrocyte differentiation and ectopic expression of Olig2
and Nkx2.2
The induction of mature OL markers by Olig2 closely
resembled the ectopic expression of Sox10 but not of Nkx2.2
(Fig. 1) implies that Sox10 is directly mediating the effects of
Olig2 on OL differentiation. To test this possibility, we next
examined the effects of Sox10 over-expression on OL
development in embryonic chicken spinal cord. Starting at
3 days following Sox10 electroporation (at cE5), induction of
late differentiation markers MAG, MBP and PLP was
observed in the electroporated side of the spinal cords (Figs.
2A–E). The induction of myelin gene expression by Sox10
occurred about 2 days earlier than that induced by Olig2.
Surprisingly, Sox10 also induced the expression of early OPC
markers Olig2 and Nkx2.2. Double labeling of MAG with
Olig2 or Nkx2.2 revealed that some of the ectopically induced
MAG+ oligodendrocytes did not co-express Olig2 (Fig. 2D) or
Nkx2.2 (Fig. 2E), suggesting that Sox10 can directly induce
myelin gene expression in the absence of Olig2 and Nkx2.2
expression. Moreover, Olig2 and Nkx2.2 were induced by
Sox10 over-expression in distinct populations of cells (Figs.
2G–H). The ectopic induction of Olig2+ and Nkx2.2+ cells
could be further confirmed by the dorsal restricted expression
of Sox10 (Fig. 2I–J; data not shown), ruling out the possibility
that the ectopic Olig2+ or Nkx2.2+ cells resulted from the
Sox10-induced dorsal migration of ventrally derived OPCs.
Together, there results suggested that MAG, Olig2 and Nkx2.2
can be induced by Sox10 independently of each other.
Fig. 1. Induction of oligodendrocyte cells by Olig2 expression in embryonic chicken spinal cords. Stage 12–13 chicken embryos were electroporated with RCABSP–Olig2 expression vector and allowed to develop
further for 4 days (A–D) or 5 days (E–J). Spinal cord sections were then subjected to in situ hybridization with Sox10 (B, F) orMBP (D, H) riboprobes, or subjected to immunofluorescent staining with anti-Olig2 (A, E),
anti-Nkx2.2 (C, G), or anti-Olig2 and anti-MAG simultaneously followed by laser confocal scanning (I, J). Panel J is a higher magnification of the outlined area in panel I. Induction of Nkx2.2 by Olig2 in the white matter

















Fig. 2. Induction of both early and late oligodendrocyte markers by ectopic expression of Sox10 for 3 days in embryonic chicken spinal cords. (A–F) Induction of
oligodendrocyte markers after Sox10 expression in one experiment. Note that many MAG+ cells in the dorsal spinal cord did not co-express Olig2 or Nkx2.2 (D,
E). (G, H) Independent induction of Olig2 and Nkx2.2 by Sox10 over-expression. Sox10 transgene expression was detected by Myc. (I, J) Induction of Olig2 by
dorsal restricted expression of Sox10.
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dosage of Olig2, Sox10 and Nkx2.2 transcription factors
The induction of OL differentiation by a prolonged activation
of Olig2 pathway in chicken embryos implicates that OL
development may be sensitive to the dosage or level of Olig2
expression in the developing spinal cord. To investigate this
possibility, we first compared the expression of mature OL
markers in E18.5 mouse spinal cords with different dosages of
Olig2 expression. At this stage, many MBP+ and PLP+
oligodendrocytes were found in the white matter region of the
wild-type embryos, but none in the Olig2 homozygous mutants
(Figs. 3A–C; Lu et al., 2002, Takebayashi et al., 2002). In the
heterozygous animals, the number of MBP+ /PLP+ mature OLs
was significantly reduced compared to that in the wild-type tissues
(Figs. 3A, B, M). The number of Olig2+, Sox10+ and Nkx2.2+
OPCs was similarly reduced in the heterozygous embryos (Figs.
3D–M). The reduction in the expressions of Olig2, MBP, PLP
and Sox10 in heterozygous embryoswas further confirmed byRT-
PCR (Figs. 3N, O). The decrease in the number of OPCs and OLs
in Olig2+/− embryos did not appear to result from an increased
apoptosis, as cell death detected by Caspase 3 immunostaining
(Figs. S2A–C) orTUNEL staining (data not shown)was similar in
all three genotypes. These observations demonstrated that the
Olig2 activation of OL differentiation in the spinal cord is
dependent on the gene dosage of Olig2.
The observation that Olig2 controls the expression of Sox10
and Nkx2.2 in oligodendrocyte cells (Figs. 1 and 3) raises the
possibility that regulation of oligodendrocyte differentiation by
these two transcription factors could also be a dosage-dependent
developmental process. To investigate this possibility, we
systematically studied the expression of myelin genes in
E18.5 spinal cords of Sox10+/− and Nkx2.2+/− animals (Stolt
et al., 2002; Qi et al., 2001; Lu et al., 2002). At this stage,expression of MBP and PLP was observed in the white matter of
wild-type (Fig. 4A) but not Sox10 and Nkx2.2 homozygous
mutant tissues (Figs. 4E–F). As in Olig2+/− embryos, the
number of MBP+ /PLP+ mature OLs in these two heterozygotes
was significantly smaller than that in the wild-type tissues (Figs.
4B, C, G). The reduction of MBP expression was previously
noticed in Sox10+/− embryos (Stolt et al., 2004). In addition, in
the Sox10+/− and Nkx2.2+/− double heterozygous animals, the
number of MBP+ /PLP+ oligodendrocytes was further
decreased, suggesting that Sox10 and Nkx2.2 mutations have
an additive or synergistic effects on OL differentiation.
Sox10 mutation leads to a reduced number of Olig2+ and
Nkx2.2+ OPCs in the spinal cord
The observation that Sox10 over-expression resulted in an
increase of Olig2+ cells and later Nkx2.2+ cells (Fig. 2) raises
the possibility that Sox10 may regulate the expression of Olig2
and Nkx2.2. To investigate this possibility, we first examined the
expression of Olig2 in Sox10mutant spinal cords. At the onset of
oligodendrogenesis (E12.5), Olig2+ OPCs started to migrate out
of the ventricular zone (VZ) in all three genotypes. However, the
number of Olig2+ cells in the ventral ventricular zone (pMN
domain) and the mantle zone was slightly decreased in both
Sox10 heterozygous and homozygous tissues (Figs. 5A–C, J).
BrdU pulse for two hours revealed a similar cycling rate of
Olig2+ cells in all three genotypes (Figs. 5A–C, K). The reduc-
tion of Olig2+ OPCs in the mutant tissues remained apparent at
E13.5 (Fig. S1) and E18.5 (Figs. 5D–F, L). The decrease in the
number of OPCs in Sox10mutant embryos could not be account-
ed for by differential survival, as a similar apoptosis rate was
observed in all three genotypes (Figs. S2D–F). Together, these
results suggested that Sox10 may play a role in up-regulating or
sustaining Olig2 gene expression in oligodendrocyte cells.
Fig. 3. Delayed oligodendrocyte differentiation inOlig2 heterozygous animals. (A–L) Transverse spinal cord sections at the thoracic level from E18.5 wild-type (A, D,
G, J), Olig2+/− (B, E, H, K) andOlig2−/− (C, F, I, L) embryos were subjected to in situ hybridization with MBP (A–C) riboprobe, or immunostaining with anti-Olig2
(D–F) and anti-Sox10 (G–I) and anti-Nkx2.2 (J–L). Expression of these markers was significantly reduced in the heterozygous tissues compared to that in the wild-
type animals. (M) Statistical analyses of MBP+ cells, Sox10+ cells, and Nkx2.2+ cells in the white matter (those in the gray matter likely represent V3 interneurons) in
Olig2 heterozygous embryos relative to wild-type embryos. (N) Semi-quantitative RT-PCR from two different groups of wild-type and heterozygous P0 spinal cord
tissues. (O) Quantitation of RT-PCR products in Olig2+/− tissues relative to the wild-type tissues.
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regulation in Olig2+ OPCs, we examined the expression and
distribution of Nkx2.2+ OPCs in E18.5 spinal cord. At this
stage, Nkx2.2+ differentiating OPCs were predominantly
located in the white matter region of wild-type tissue (Qi etal., 2001), whereas the Nkx2.2-immunoreactive cells in the gray
matter likely represented V3 interneurons (Liu et al., 2003). A
smaller number of Nkx2.2+ differentiating OPCs was observed
in the white matter of Sox10+/− spinal cord and a further
reduction was detected in the homozygous mutants (Figs. 5G–I,
Fig. 4. Delayed oligodendrocyte differentiation in Sox10+/− and Nkx2.2+/− heterozygous animals. (A–F) Transverse spinal cord sections at the thoracic level from
E18.5 various mutant embryos were subjected to in situ hybridization with MBP riboprobe. (G) Statistical analyses of MBP+ and PLP+ oligodendrocytes in Sox10 and
Nkx2.2 heterozygous and homozygous embryos. The number of MBP+ and PLP+ cells was significantly reduced in single heterozygous animals, and further reduced
in Sox10+/−; Nkx2.2+/− double heterozygotes.
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Olig2+ cells that co-expressed Nkx2.2 was markedly reduced
(Figs. 6A–C), suggesting that Sox10 also modulates Nkx2.2
expression in undifferentiated Olig2+ OPC cells.
Nkx2.2 mutation did not affect Olig2 and Sox10 expression in
OPC cells
We next investigated whether Nkx2.2 activity can regulate
Olig2 and Sox10 expression at later stages of OL development.
At E18.5, a slightly larger number of Sox10+ and Olig2+ OPC
cells were observed in Nkx2.2 mutant spinal cord (Figs. 6D–F),
likely due to an expanded pMN domain and subsequently
increased production of OPCs at earlier stages (Qi et al., 2001).
Double immunostaining revealed that the percentage of Olig2+
cells that co-expressed Sox10 was not significantly altered byNkx2.2 mutation (Figs. 6D–F), indicating that Nkx2.2 does not
regulate Sox10 expression in Olig2+ OPCs. Since myelin gene
expression was greatly inhibited in Nkx2.2 mutant spinal cords
at this stage (Fig. 4F), it also suggested that during normal
development, expression of Olig2 and Sox10 in Nkx2.2 mutants
is not sufficient for driving OL differentiation and the Nkx2.2
activity is additionally required to fully achieve the differentia-
tion process.
Discussion
In this study, we presented the first in vivo evidence that
ectopic expression of Olig2 or Sox10 alone was sufficient for
inducing myelin gene expression in the developing spinal cord.
Sox10 and Nkx2.2 appear to function in parallel to regulate OL
differentiation process. In addition, we demonstrated that
Fig. 5. Reduced expression of Olig2 and Nkx2.2 in Sox10 mutant embryos. (A–C) E12.5 wild-type (A), Sox10+/− (B) and Sox10−/− (C) embryos were pulse-
labeled with BrdU for 2 h and transverse spinal cord sections were subjected to double immunolabeling with anti-BrdU (green) and anti-Olig2 (red). (D–I) Spinal
cord sections from E18.5 wild-type (D, G), Sox10+/− (E, H) and Sox10−/− (F, I) embryos were subjected to immunostaining with anti-Olig2 (D–F) or anti-Nkx2.2
(G–I). Expression of these markers was significantly reduced in the heterozygous tissues compared to that in the wild-type animals. (J) Number of Olig2+ cells in
E12.5 Sox10+/− and Sox10−/− embryos relative to the wild-type embryos. (K) Percentage of Olig2+ cells that incorporated BrdU at E12.5 in all three genotypes.
(J) Number of Olig2+ and Nkx2.2+ cells in E18.5 Sox10+/− and Sox10−/− embryos relative to the wild-type embryos.
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and Nkx2.2 is a dosage-dependent developmental process.
Sox10 mediates the Olig2 induction of oligodendrocyte
differentiation and myelin gene expression
Olig2 plays an essential role in the fate specification of OL
lineage, and null mutation of Olig2 resulted in a complete loss
of cells of the oligodendrocyte lineage in the spinal cord (Lu et
al., 2002; Takebayashi et al., 2002; Zhou and Anderson, 2002).
However, it was also demonstrated that expression of Olig2alone was not sufficient for induction of OL development, and
co-expression of Nkx2.2 was required for terminal differentia-
tion of OLs (Sun et al., 2001; Zhou et al., 2001). In the present
study, we demonstrated that expression of Olig2 alone for
4 days was able to induce the early OPC marker Sox10, and a
slightly prolonged expression of Olig2 (for 5 days) can further
induce expression of the late OPC marker Nkx2.2 and mature
markers MAG, MBP and PLP (Fig. 1). The discrepancy
between the present and previous over-expression studies could
be accounted for by both the expression level and duration of
Olig2 expression. In our studies, we employed a higher
Fig. 6. Cross-regulation of Olig2, Sox10 and Nkx2.2 expression in oligodendrocyte cells. (A–C) Sox10 mutation affects the expression of Nkx2.2 in Olig2+ OPCs.
E18.5 spinal cord sections from wild-type (A) and Sox10−/− (B) embryos were simultaneously immunostained with antibodies against Olig2 and Nkx2.2, and the
percentage of Olig2+ cells that co-express Nkx2.2 in wild-type and Sox10 mutants was calculated (C). (D–F) Nkx2.2mutation does not reduce the expression of Olig2
and Sox10. E18.5 spinal cord sections from wild-type (D) and Nkx2.2−/− (E) embryos were simultaneously immunostained with antibodies against Olig2 and Sox10,
and the percentage of Olig2+ cells that co-expressed Sox10 in wild-type and Nkx2.2 mutants was calculated (F).
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vectors to achieve a robust and sustained expression of Olig2
for a longer time period. Ectopic expression of mature OL
markers was difficult to detect in embryos electroporated with
1 μg/μl or lower concentration of Olig2 expression vector (data
not shown), consistent with the concept of dosage-dependent
activation of OL differentiation by oligodendrocyte lineage
transcription factors (as discussed below).
Sox10 appears to directly mediate the effects of Olig2 on
oligodendrocyte differentiation based on the present and some
previous studies. Firstly, in Olig2-transfected spinal cord, the
pattern of induced MBP and PLP expression closely resembled
that of ectopic Sox10 expression (Fig. 1). Secondly, expression
of Sox10 alone in chicken spinal cord was able to induce
expression of myelin genes MAG, MBP and PLP in a much
shortened time frame (Fig. 2), as compared to the Olig2
induction of myelin gene expression. Thirdly, loss of Sox10
activity resulted in a severe reduction of myelin gene
expression and OL differentiation (Stolt et al., 2002). In
light of the findings that Sox10 is the only transcription factor
that is known to be expressed in myelin-forming cells in both
CNS and PNS and its mutation affects myelin gene expression
in both tissues (Wegner and Stolt, 2005), it is possible that
Sox10 may be directly responsible for stimulating myelin-
specific gene expression and cell differentiation in oligoden-
drocytes and Schwann cells. Previous studies demonstrated
that over-expression of Sox10 and its related SoxE member
Sox9 also induced neural crest-like phenotype at the expense
of neurogenesis (Cheung and Briscoe, 2003; McKeown et al.,2005). Thus, Sox10 functions to promote glial genesis and
suppress neurogenesis during neural development. At early
stages, Sox10 is expressed in the dorsal tips and promotes the
formation and migration of neural crest precursor cells,
whereas at later stages, it is expressed in OPCs (Stolt et al.,
2002) and promotes the terminal differentiation of oligoden-
drocytes in the CNS. Ectopic and sustained expression of
Sox10 in young embryonic spinal cord appeared to recapitulate
both functions.
Sox10 and Nkx2.2 function in parallel to control
oligodendrocyte differentiation
Sox10 and Nkx2.2 are both required for OL differentiation
and maturation, and mutations in these two transcription factors
exhibit similar phenotypes with delayed and retarded OL
differentiation (Qi et al., 2001; Stolt et al., 2002). In their
heterozygous embryos, the differentiation of oligodendrocytes
is significantly decreased and delayed. Interestingly, there is
a further reduction of oligodendrocyte differentiation in the
Sox10+/− and Nkx2.2+/− double heterozygous animals (Fig.
4), suggesting that Nkx2.2 and Sox10 have synergistic effects
on OL differentiation.
Despite the observations that Sox10 over-expression can
directly stimulate myelin gene expression (Fig. 2; Stolt et al.,
2002; Wei et al., 2004), normal expression of Sox10 in OPCs
did not appear to be sufficient for OL differentiation in vivo. In
E18.5 Nkx2.2 null mutants, expression of both Sox10 and Olig2
was not compromised (Fig. 6) but OL differentiation was
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CNS development, Sox10 activation of MBP/PLP genes is
negatively regulated by an unknown inhibitory molecule. Given
that Nkx2.2 primarily functions as a transcriptional repressor
during neural development (Muhr et al., 2001; Zhou et al.,
2001; Wei et al., 2005), it is possible that Nkx2.2 may regulate
the terminal differentiation of oligodendrocytes in an indirect
manner. Conceivably, Nkx2.2 may repress the expression or
activity of an inhibitory factor that prevents OL differentiation
and myelin gene expression.
Taken into account all these observations, we propose that
oligodendrocyte differentiation is controlled by two parallel
pathways, a positive regulatory pathway mediated through
Sox10 and an inhibitory pathway mediated by an unknown
factor whose expression or activity can be repressed by Nkx2.2
(Fig. 7). While Sox10 may directly stimulate gene expression
from myelin gene promoters, Nkx2.2 might repress the
expression or activity of the inhibitory factor. It is conceivable
that in OPC cells, this hypothetical inhibitory factor can bind to
Sox10 protein and therefore interfere with Sox10 activity.
Nkx2.2 may repress its expression as a transcription repressor or
its activity by physical association with this inhibitory factor. In
this regard, Nkx2.2 protein may facilitate Olig2- and Sox10-
mediated OL differentiation and function to control the timing
of OL differentiation. However, a constitutive high level of
Sox10 or Olig2 expression can obviate the requirement of
Nkx2.2 in OL differentiation and lead to ectopic myelin gene
expression in the absence of Nkx2.2 activity (Fig. 2).
Regulation of Olig2 and Nkx2.2 expression by Sox10 in OPC
cells
Although genetic studies have established that Sox10
functions downstream of Olig2 (Lu et al., 2002; Takebayashi
et al., 2002; Zhou and Anderson, 2002), both gain- and loss-of-
function studies suggested that there is a reciprocal regulation of
Olig2 and Sox10 expression in oligodendrocyte cells. In
embryonic chicken spinal cord, over-expression of Sox10 can
weakly induce Olig2 expression (Fig. 2). Conversely, mutationFig. 7. A hypothetical hierarchy and functional interaction of transcription
factors that control oligodendrocyte development. Dashes represent weak
regulations.of Sox10 gene resulted in a decreased expression of Olig2 in the
spinal cord (Figs. 5 and 6). The small reduction of Olig2+ OPCs
was previously unnoticed by in situ RNA hybridization (Stolt et
al., 2002) possibly due to its lower detection sensitivity. The
positive feedback on Olig2 expression by Sox10 also implies
that Sox10may have an important function in up-regulating and/
or maintaining Olig2 expression during oligodendrocyte
development.
Similarly, Sox10 expression can also regulate Nkx2.2
expression, and this regulatory relationship may contribute to
the up-regulation of Nkx2.2 protein in differentiating OPCs
(Fig. 7). In the absence of Sox10 function, Nkx2.2 expression is
dramatically down-regulated but not completely inhibited (Fig.
6). Conversely, over-expression of Sox10 can promote Nkx2.2
expression in embryonic spinal cord independently of Olig2
induction (Fig. 2), suggesting that the induction of Nkx2.2 and
Olig2 by Sox10 is mediated by distinct molecular pathways or
mechanisms.
Dosage-dependent regulation of oligodendrocyte development
by transcriptional factors
The haploinsufficiency in OL differentiation was previously
reported for the Sox10 transcriptional regulator (Stolt et al.,
2004). Here we showed that the delayed maturation of OLs was
also observed in Olig2 and Nkx2.2 heterozygous animals,
indicating that the OL differentiation process is particularly
sensitive to the gene dosage of these transcriptional factors. The
dosage-dependent OL development could also explain the
delayed OL differentiation phenotype in other mutants (e.g.
Nkx6.1−/− and Gli2−/− mutants) in which the Olig2 expression
in the pMN domain was markedly reduced at the stage of
gliogenesis (Liu et al., 2003; Qi et al., 2003).
The developmental defects caused by haploinsufficiency
have recently been noticed for a number of other transcription
factors in a diversity of developmental processes (Aoki et al.,
2004; Bland et al., 2000; Kalinichenko et al., 2004). For
instance, a decrease in Sox9 dosage by haploinsufficiency in
neural crest-derived tissues resulted in delayed frontal cranial
suture closure (Sahar et al., 2005). Mice heterozygous for Pax6
mutations display small eyes (Sey) phenotype with a small lens
(van Raamsdonk and Tilghman, 2000). Although many
transcription factor genes display semi-dominant loss-of-
function heterozygous phenotypes, the underlying mechanism
for this dosage requirement is not known. One plausible
explanation is that a critical threshold of transcription factors is
required for cell differentiation and that the time in development
for reaching this threshold level is delayed in heterozygotes.
Consistent with this hypothesis, oligodendrocyte differentiation
and maturation is simply delayed in animals heterozygous for
Olig2, Sox10 and Nkx2.2. However, the initial delay of OL
differentiation in these heterozygous animals is at least in part
compensated during further development, given the more or
less normal oligodendrocyte phenotype in adult heterozygous
mice. In further support of the threshold theory, a strong or
prolonged activation of the Olig2 or Sox10 pathway is capable
of promoting ectopic and precocious OL differentiation and
692 Z. Liu et al. / Developmental Biology 302 (2007) 683–693myelin gene expression (Figs. 1 and 2). Therefore, OL
differentiation appears to be exquisitely sensitive to the dosage
of Olig2/Sox10 gene expression and can be affected by both
haploinsufficiency and overdosage. A similar mechanism may
operate in the control of skeletal growth by the SHOX
homeodomain transcription factor in human development
(Ogata et al., 2001).
Experimental procedures
Genotyping of Olig2, Sox10 and Nkx2.2 mutant mice
The Olig2, Sox10 and Nkx2.2 homozygous null embryos were obtained by
the interbreeding of double heterozygous animals. Genomic DNA extracted
from embryonic tissues or mouse tails was used for genotyping by Southern
analysis or by PCR. Genotyping of Olig2, Sox10 and Nkx2.2 loci was described
earlier (Lu et al., 2002; Stolt et al., 2002; Qi et al., 2001).
In situ RNA hybridization and immunofluorescent staining
Spinal cord tissues at the thoracic level were isolated from E10.5 to E18.5
mouse embryos and then fixed in 4% paraformaldehyde at 4°C overnight.
Following fixation, tissues were transferred to 20% sucrose in PBS overnight,
embedded in OCT media and then sectioned (20 μm thickness) on a cryostat.
Adjacent sections from the wild-type and mutant embryos were subsequently
subjected to in situ hybridization (ISH) or immunofluorescent staining. ISH
was performed as described in Schaeren-Wiemers and Gerfin-Moser (1993)
with minor modifications, and the detailed protocol is available upon request.
Double immunofluorescent procedures were previously described in Xu et al.
(2000). The dilution ratio of antibodies is as follows: anti-Olig2 (1:6000), anti-
MAG (Chemicon, 1:500), anti-Myc (Sigma, 1:50), anti-Nkx2.2 (DSHB, 1:50),
anti-Sox10 (1:3000; Stolt et al., 2003) and anti-caspase 3 (Cell Signaling,
1:400).
Semi-quantitative RT-PCR
Total RNA was extracted from spinal cord of P0 wt and Olig2+/− mice by
using Trizol (Invitrogen). The concentration of total RNA was assessed by
spectrophotometry and adjusted roughly to the same concentrations among
samples. First-strand cDNAwas generated by using SuperScript III first-strand
synthesis system (Invitrogen). To ensure that PCR cycles ended before
saturation, generally, the cycle number for each primer was first tried at 27
cycles and then decreased or increased 2–5 cycles, depending on the intensity of
the initial PCR products. Therefore, each group of samples were run for PCR
with at least two or three different cycle numbers to select the reaction showing
clear bands with the lowest cycle number. Three different groups of samples
were used. Primers for a housekeeping gene (GAPDH) were used as a control.
Primer sequences used for analyses are as follows: GAPDH, forward 5′-
ggccttccgtgttcctac-3′, reverse 5′-ctgttgctgtagccgtattca-3′; MBP, forward 5′-
ccctcagagtccgacgagctt-3′, reverse 5′-tcccttgtgagccgatttat-3′; Nkx2.2, forward
5′-gaccttccggacaccaacgat-3′, reverse 5′-gcgagggcagaggcgtcac-3′; Olig2, for-
ward 5′-ccgaaaggtgtggatgcttat-3′, reverse 5′-tcgctcaccagtcgcttcat-3′; PLP,
forward 5′-gacatgaagctctcactggtac-3′, reverse 5′-catacattctggcatcagcgc-3′;
Sox10, forward 5′-aagagcaagccgcacgtc-3′, reverse 5′-acgttgccgaagtcgatgtgg-3′.
In ovo electroporation
Full-lengths mouse Olig2, Sox10 and Nkx2.2 cDNAs were subcloned into
the replication-competent retroviral vector RCASBP(B) (Morgan and Fekete,
1996). For in ovo electroporation, about 1.5 μl (2 μg/μl) of expression vectors
was injected into stage 12–13 white horn chicken embryos with the aid of
Picospritzer III instrument. The injected embryos were then subjected to three
short-pulses of electrical shock (25 V, 50 ms for each pulse) and allowed to
develop for various time periods before they were fixed in 4% PFA for gene
expression studies.Acknowledgments
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